Evening oral insulin (ORMD-0801) glycaemic effects in uncontrolled type 2 diabetes patients

被引：0
|
作者：
Eldor, R. [1 ]
Fleming, A. [2 ]
Neutel, J. [3 ]
Homer, K. [4 ]
Kidron, M. [5 ]
Rosenstock, J. [6 ]
机构：
[1] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel
[2] Kinexum, Harpers Ferry, WV USA
[3] Orange Cty Heart Inst & Res Ctr, Tustin, CA USA
[4] Integrium LLC, Tustin, CA USA
[5] Oramed Pharmaceut, Jerusalem, Israel
[6] Dallas Diabet Res Ctr, Dallas, TX USA
来源：
DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
60
引用
下载
收藏
页码：S30 / S31
页数：2
相关论文
共 50 条
  • [41] Effects of metformin on glycaemic variability in combination with insulin in overweight/obese patients with type 1 diabetes
    Shean, Wong Poh
    Voon, Tong Chin
    Bidin, Mohamed Badrulnizam Bin Long
    Adam, Noor Lita Binti
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2023, 53 (02): : 94 - 103
  • [42] A Diabetes- specific Oral Nutritional Supplement Improves Glycaemic Control in Type 2 Diabetes Patients
    Mayr, P.
    Kuhn, K. S.
    Klein, P.
    Stover, J. F.
    Pestana, E. A.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2016, 124 (07) : 401 - 409
  • [43] Perceptions of diabetes control among physicians and patients with uncontrolled type 2 diabetes using basal insulin
    Brod, M.
    Pfeiffer, K. M.
    Barnett, A. H.
    Berntorp, K.
    Vilsboll, T.
    Weissenberger, B.
    DIABETOLOGIA, 2015, 58 : S428 - S429
  • [44] Treatment Satisfaction With Albiglutide and Liraglutide in Patients With Type 2 Diabetes Uncontrolled With Oral Therapy
    Martin, Alan A.
    Johnson, Susan L.
    Ye, June
    Pratley, Richard E.
    DIABETES, 2013, 62 : A259 - A260
  • [45] The effects of insulin and oral antidiabetic agents on oxidative stress and inflammation in patients with type 2 diabetes
    Herskovits, A
    Shurtz-Swirski, R
    Rastaski, V
    Kristal, B
    Chezar, J
    Michelis, R
    Sela, S
    DIABETES, 2003, 52 : A475 - A475
  • [46] Effects of beraprost sodium, an oral prostacyclin analog, on insulin resistance in patients with type 2 diabetes
    Katsuyama H.
    Kubota N.
    Kubota T.
    Haraguchi M.
    Obata A.
    Takamoto I.
    Shigematsu K.
    Miyata T.
    Ueki K.
    Kadowaki T.
    Diabetology International, 2015, 6 (1) : 39 - 45
  • [47] Switching to insulin glargine 300 U/ml in patients with type 2 diabetes on basal insulin supported oral therapy (BOT) improves glycaemic control
    Seufert, J.
    Fritsche, A.
    Anderten, H.
    Pegelow, K.
    Pscherer, S.
    Pfohl, M.
    DIABETOLOGIA, 2018, 61 : S441 - S441
  • [48] Age and Other Factors Predicting Insulin Intensification Strategies in Patients With Type 2 Diabetes (T2DM) Uncontrolled on Oral Diabetes Medication (ODM)
    Korytkowski, Mary T.
    Lombardero, Manuel
    Brooks, Maria M.
    Orchard, Trevor J.
    Kanter, Justin
    Dealmeida, Dilhari
    Siminerio, Linda M.
    DIABETES, 2013, 62 : A650 - A650
  • [49] Effects of the rapid-acting insulin analogue Insulin Aspart on postprandial glycaemic excursions in type 2 diabetes
    Thorsby, P
    Rosenfalck, AM
    Kjems, L
    Hanssen, KF
    Madsbad, S
    Birkeland, KI
    DIABETOLOGIA, 1999, 42 : A17 - A17
  • [50] Effects of improved glycaemic control on endothelial function in patients with type 2 diabetes
    Bagg, W
    Whalley, GA
    Gamble, G
    Drury, PL
    Sharpe, N
    Braatvedt, GD
    INTERNAL MEDICINE JOURNAL, 2001, 31 (06) : 322 - 328
12345